Navigating Federal Health Policy in the 119th Congress

Government and regulatory consulting principal Megan Herber and consulting directors Elliot Vice and Nisha Quasba authored an article for Innovations Magazine titled, “Navigating Federal Health Policy in the 119th Congress.” The article examines the significant changes following the 2024 presidential and congressional elections that resulted in a Republican trifecta government, and its implications on health policy, particularly for the pharmacy regulatory space. The authors consider how policies such as drug importation, drug pricing, and the potential repeal of the ACA and IRA could evolve under the new government.